1. Search Result
Search Result
Results for "

VD

" in MedChemExpress (MCE) Product Catalog:

30

Inhibitors & Agonists

1

Peptides

5

Natural
Products

9

Isotope-Labeled Compounds

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-145263A

    Others Cancer
    VD2173 epimer-1 is a racemic mixture of VD2173 (HY-145263) .
    VD2173 epimer-1
  • HY-15331

    Vitamin D3-26,26,26,27,27,27-d6

    VD/VDR Metabolic Disease
    VD3-d6 (Vitamin D3-26,26,26,27,27,27-d6) is deuterated VD3. Compounds labeled with stable or radioactive isotopes can be used in metabolic analysis, allowing the movement of individual atoms to be precisely tracked and quantified .
    VD3-d6
  • HY-15330

    Ergocalciferol-d3; Calciferol-d3; VD2-d3

    VD/VDR Metabolic Disease
    Vitamin D2-d3 (Ergocalciferol-d3) is the deuterium labeled vitamin D2.
    Vitamin D2-d3
  • HY-15328

    VD/VDR Metabolic Disease
    25-Hydroxy VD2-d6 is the deuterium labeled 25-Hydroxy VD2.
    25-Hydroxy VD2-d6
  • HY-52121

    Others Others
    Windaus ketone is a VD building blocker.
    Windaus ketone
  • HY-145263

    Ser/Thr Protease Cancer
    VD2173 is a side chain cyclized macrocyclic peptide inhibitor of HGF-activating serine proteases. VD2173 potently inhibits matriptase and hepsin. VD2173 can be used for the research of lung cancer .
    VD2173
  • HY-161371

    Ser/Thr Protease Cancer
    VD5123 is a serine protease inhibitor. VD5123 inhibits TMPRS2, HGFA, matriptase, hepsin with IC50s of 15, 3980, 140, 37 nM respectively. VD5123 can be used for antiviral research, such as SARS-CoV-2 and broad panel of coronaviruses and influenza viruses .
    VD5123
  • HY-161370

    Ser/Thr Protease Cancer
    VD4162 (Compound 8b) is a macrocyclic inhibitor of serine proteases. VD4162 can significantly improve potency for all four target enzymes TMPRSS2 (IC50 = 3.7 nM), HGFA(IC50 = 3.3 nM), matriptase (IC50 = 2.9 nM), and hepsin (IC50 = 0.54 nM). VD4162 can be used for the research of cancer .
    VD4162
  • HY-15327

    Isotope-Labeled Compounds VD/VDR Metabolic Disease
    1alpha, 25-Dihydroxy VD2-d66 is a deuterated form of vitamin D.
    1alpha, 25-Dihydroxy VD2-d6
  • HY-12305A

    (R)-QVD-OPH; (R)-Quinoline-Val-Asp-Difluorophenoxymethylketone

    Apoptosis Cancer
    (R)-Q-VD-OPh ((R)-QVD-OPH) is the less active enantiomer of Q-VD-OPha. Q-VD-OPha is an irreversible pan-caspase inhibitor with potent antiapoptotic properties.
    (R)-Q-VD-OPh
  • HY-12305
    Q-VD-OPh
    Maximum Cited Publications
    53 Publications Verification

    QVD-OPH; Quinoline-Val-Asp-Difluorophenoxymethylketone

    Caspase HIV Infection Cancer
    Q-VD-OPh is an irreversible pan-caspase inhibitor with potent antiapoptotic properties; inhibits caspase 7 with an IC50 of 48 nM and 25-400 nM for other caspases including caspase 1, 3, 8, 9, 10, and 12. Q-VD-OPh can inhibits HIV infection. Q-VD-OPh is able to cross the blood-brain barrier.
    Q-VD-OPh
  • HY-15156

    VD/VDR Metabolic Disease
    1alpha, 24, 25-Trihydroxy VD2 is a vitamin D analog.
    1alpha, 24, 25-Trihydroxy VD2
  • HY-76915

    VD/VDR Endogenous Metabolite Metabolic Disease
    24, 25-Dihydroxy VD3 is a compound closely related to 1,25-dihydroxyvitamin D3 and is the active form of vitamin D3 .
    24, 25-Dihydroxy VD3
  • HY-15157

    1α, 24, 25-Trihydroxy VD3

    VD/VDR Metabolic Disease
    Calcitetrol(1α, 24, 25-Trihydroxy VD3) is the hormonally active form of vitamin D with three hydroxyl groups.
    Calcitetrol
  • HY-76801
    24, 25-Dihydroxy VD2
    1 Publications Verification

    24,25-Dihydroxy vitamin D2

    VD/VDR Drug Metabolite Metabolic Disease
    24, 25-Dihydroxy VD2 is a hydroxylated metabolite of Vitamin D2; a synthetic analog of Vitamin D.
    24, 25-Dihydroxy VD2
  • HY-100219

    VD/VDR Cancer
    CB1151 is a 20-epi analogue of 1,25 dihydroxyvitamin D3 (VD) with potent anti-tumor effects. CB1151 inhibits MCF-7 cell growth with an IC50 value of 0.82 nM .
    CB1151
  • HY-13249

    1α-Hydroxy vitamin D4

    VD/VDR Cancer
    1alpha-Hydroxy VD4 , a 1alpha(OH)D derivative, can effectively induce the differentiation of monoblastic leukaemia U937, P39/TSU and P31/FUJ cells.
    1alpha-Hydroxy VD4
  • HY-32351
    Calcifediol
    5+ Cited Publications

    25-hydroxy Vitamin D3

    VD/VDR Endogenous Metabolite Metabolic Disease
    Calcifediol (25-hydroxy Vitamin D3) is an effective VDR ligand and VD supplement. Calcifediol is a prohormone of the vitamin D endocrine system (VDES) and is hydroxylated in the liver to produce the active form, calcitriol. Calcifediol can rapidly increase serum VD levels .
    Calcifediol
  • HY-32351A
    Calcifediol monohydrate
    5+ Cited Publications

    25-hydroxy Vitamin D3 monohydrate

    VD/VDR Endogenous Metabolite Metabolic Disease
    Calcifediol monohydrate (25-hydroxy Vitamin D3 monohydrate), is an effective VDR ligand and VD supplement. Calcifediol is a prohormone of the vitamin D endocrine system (VDES) and is hydroxylated in the liver to produce the active form, calcitriol. Calcifediol can rapidly increase serum VD levels .
    Calcifediol monohydrate
  • HY-32351S

    25-hydroxy Vitamin D3-d3

    VD/VDR Endogenous Metabolite Metabolic Disease
    Calcifediol-d3 is a deuterium labeled Calcifediol. Calcifediol, is an effective VDR ligand and VD supplement. Calcifediol is a prohormone of the vitamin D endocrine system (VDES) and is hydroxylated in the liver to produce the active form, calcitriol. Calcifediol can rapidly increase serum VD levels .
    Calcifediol-d3
  • HY-32351AS

    25-hydroxy Vitamin D3-d6 monohydrate

    Isotope-Labeled Compounds VD/VDR Endogenous Metabolite Metabolic Disease
    Calcifediol-d6 monohydrate is the deuterium labeled Calcifediol monohydrate. Calcifediol monohydrate (25-hydroxy Vitamin D3 monohydrate), is an effective VDR ligand and VD supplement. Calcifediol is a prohormone of the vitamin D endocrine system (VDES) and is hydroxylated in the liver to produce the active form, calcitriol. Calcifediol can rapidly increase serum VD levels .
    Calcifediol-d6 monohydrate
  • HY-32351AR

    VD/VDR Endogenous Metabolite Metabolic Disease
    Calcifediol monohydrate (Standard) is the analytical standard of Calcifediol (monohydrate). This product is intended for research and analytical applications. Calcifediol monohydrate (25-hydroxy Vitamin D3 monohydrate), is an effective VDR ligand and VD supplement. Calcifediol is a prohormone of the vitamin D endocrine system (VDES) and is hydroxylated in the liver to produce the active form, calcitriol. Calcifediol can rapidly increase serum VD levels .
    Calcifediol monohydrate (Standard)
  • HY-32351AS1

    25-Hydroxy Vitamin D3-13C5 monohydrate

    Isotope-Labeled Compounds VD/VDR Endogenous Metabolite Metabolic Disease
    Calcifediol- 13C5 monohydrate is the 13C-labeled Calcifediol monohydrate. Calcifediol monohydrate (25-hydroxy Vitamin D3 monohydrate), is an effective VDR ligand and VD supplement. Calcifediol is a prohormone of the vitamin D endocrine system (VDES) and is hydroxylated in the liver to produce the active form, calcitriol. Calcifediol can rapidly increase serum VD levels .
    Calcifediol-13C5 monohydrate
  • HY-32351R

    VD/VDR Endogenous Metabolite Metabolic Disease
    Calcifediol (Standard) is the analytical standard of Calcifediol. This product is intended for research and analytical applications. Calcifediol (25-hydroxy Vitamin D3) is an effective VDR ligand and VD supplement. Calcifediol is a prohormone of the vitamin D endocrine system (VDES) and is hydroxylated in the liver to produce the active form, calcitriol. Calcifediol can rapidly increase serum VD levels .
    Calcifediol (Standard)
  • HY-10397A
    MX1013
    2 Publications Verification

    CV1013; Z-VD-FMK

    Caspase Cancer
    MX1013 is a potent, irreversible dipeptide caspase inhibitor vith antiapoptotic activity. MX1013 inhibits recombinant human caspase 3 with an IC50 of 30 nM .
    MX1013
  • HY-P1008
    Z-VDVAD-FMK
    1 Publications Verification

    Z-VD(OMe)VAD(OMe)-FMK

    Caspase Cancer
    Z-VDVAD-FMK is a special inhibitor of caspase-2. Z-VDVAD-FMK produces a reduction in Lovastatin-induced apoptosis .
    Z-VDVAD-FMK
  • HY-P1008A

    Z-VD(OMe)VAD(OMe)-(DL-Asp)-FMK

    Caspase Cancer
    Z-VDVA-(DL-Asp)-FMK is a Z-VDVAD-FMK derivative. Z-VDVAD-FMK (HY-P1008) is a special inhibitor of caspase-2 .
    Z-VDVA-(DL-Asp)-FMK
  • HY-161661

    Others Cancer
    Anticancer agent 223 (Compound V-d) is an anticancer agent that triggers cell death through caspase-dependent and caspase-independent mechanisms. Anticancer agent 223 inhibits tumor spheroid formation and resensitizes cisplatin (HY-17394)-resistant A2780 cells to cisplatin (HY-17394) treatment .
    Anticancer agent 223
  • HY-B0975S1

    Phenoxymethylpenicillin-d5 potassium salt

    Bacterial Antibiotic Infection
    Penicillin V-d5 (potassium) is the deuterium labeled Penicillin V Potassium[1]. Penicillin V Potassium (Phenoxymethylpenicillin potassium salt) is an orally active antibiotic. Penicillin V Potassium inhibits the growth of Streptococci, C. difficile and S. aureus. Penicillin V Potassium can be used for the research of otitis, sinusitis, pharyngitis and tonsillitis[2][3][4][5].
    Penicillin V-d5 potassium
  • HY-B0975AS

    Isotope-Labeled Compounds Bacterial Antibiotic Infection
    Penicillin V-d5 (Phenoxymethylpenicillin-d5) is the deuterium labeled Penicillin V. Penicillin V (Phenoxymethylpenicillin) is an orally active antibiotic. Penicillin V inhibits the growth of Streptococci, C. difficile and S. aureus. Penicillin V can be used for the research of otitis, sinusitis, pharyngitis and tonsillitis[1][2][3][4].
    Penicillin V-d5

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: